Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

IMID Rheumatology
Claim This Podcastby The Immune-Mediated Inflammatory Disease Forum
Podcast Authority
Beta
Podcast Overview
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Language
🇺🇲
Publishing Since
10/21/2015
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for IMID Rheumatology
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

July 30, 2026
Discussing RA: Advanced therapy outcomes in RA
Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies by Fleischmann et al. and Nozaki et al. discussing the long-term effectiveness and safety of advanced targeted therapies for RA.

July 22, 2026
Author Interview: Professor Laura Coates, July 2026
Join Professor Peter Nash from the Griffith University in Brisbane, and Laura Coates, Professor at the University of Oxford’s Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, as they discuss a recent paper ‘Ixekizumab with tirzepatide achieved greater disease control than ixekizumab alone in adults with psoriatic arthritis and overweight or obesity: Results from a randomized clinical trial’.

July 16, 2026
Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.
410 total episodes available
Recent guests on IMID Rheumatology
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Philip Mease
Guest
Laura Coates
Guest
Professor Xenofon Baraliakos
Guest
Dr Saqr Alsakarneh
Guest
Similar Podcasts
Discover related shows you might enjoy

Rheumnow Podcast
Dr. Cush

ACR Journals On Air
American College of Rheumatology

ACR on Air
American College of Rheumatology

The Evidence Based Rheumatology Podcast
Michael Putman

Talking Rheumatology Spotlight
British Society for Rheumatology

The Lupus Forum
The Lupus Forum

Around the Rheum
Canadian Rheumatology Association

Rheumatology For The Royal College
Dr. Karim Ladak

NEJM This Week
NEJM Group

Annals On Call Podcast
American College of Physicians

JAMA Clinical Reviews
JAMA Network

The Daily
The New York Times

Up First
NPR

The Rest Is Politics: US
Goalhanger

Pod Save America
Pod Save America
Deep-dive analytics for IMID Rheumatology
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is IMID Rheumatology?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.